Detalles de la búsqueda
1.
Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 22(8): 1517-1524, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118572
2.
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Blood
; 121(15): 2864-74, 2013 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23426943
3.
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.
Blood
; 122(25): 4129-39, 2013 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24055823
4.
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.
Cytotherapy
; 15(5): 598-609, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23352462
5.
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
J Clin Oncol
; 34(10): 1112-21, 2016 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26811520
6.
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
Clin Cancer Res
; 21(19): 4312-20, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26071480
Resultados
1 -
6
de 6
1
Próxima >
>>